CUSIP: 52886N406
What is CUSIP 52886N406?
CUSIP 52886N406 identifies LEXX - Lexaria Bioscience Corp. - COM NEW in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 52886N406:
As of 31 Dec 2025, 21 institutional investors reported holding 1,701,197 shares of Lexaria Bioscience Corp. - COM NEW (LEXX).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,701,197 | $1,053,042 | -$168,784 | $0.62 | 21 |
| 2025 Q3 | 1,717,317 | $1,634,673 | -$453,765 | $0.95 | 25 |
| 2025 Q2 | 2,297,450 | $1,999,388 | +$851,079 | $0.87 | 21 |
| 2025 Q1 | 1,239,756 | $2,119,588 | -$537,170 | $1.71 | 22 |
| 2024 Q4 | 1,441,461 | $3,026,861 | +$641,163 | $2.10 | 25 |
| 2024 Q3 | 1,066,674 | $3,252,819 | -$2,740,930 | $3.05 | 27 |
| 2024 Q2 | 2,057,835 | $5,720,708 | +$3,236,557 | $2.78 | 28 |
| 2024 Q1 | 888,794 | $3,225,972 | -$347,925 | $3.63 | 25 |
| 2023 Q4 | 1,195,589 | $1,494,550 | -$493,306 | $1.25 | 19 |
| 2023 Q3 | 1,771,138 | $1,770,635 | +$883,097 | $1.00 | 14 |
| 2023 Q2 | 892,281 | $651,351 | +$101,928 | $0.73 | 12 |
| 2023 Q1 | 678,680 | $1,846,092 | -$42,025 | $2.72 | 15 |
| 2022 Q4 | 695,981 | $1,709,524 | +$22,671 | $2.46 | 15 |
| 2022 Q3 | 686,764 | $1,681,000 | +$290,061 | $2.45 | 14 |
| 2022 Q2 | 561,124 | $1,671,000 | +$261,493 | $2.98 | 15 |
| 2022 Q1 | 472,493 | $1,410,000 | +$54,741 | $3.29 | 11 |
| 2021 Q4 | 456,920 | $1,849,000 | -$8,044 | $4.04 | 10 |
| 2021 Q3 | 451,867 | $2,828,000 | +$205,881 | $6.26 | 9 |
| 2021 Q2 | 416,999 | $2,923,000 | +$713,924 | $7.00 | 8 |
| 2021 Q1 | 317,785 | $1,783,000 | +$1,783,000 | $5.61 | 7 |